National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 873194

History of Changes from the VAERS Wayback Machine

First Appeared on 10/14/2020

VAERS ID: 873194
VAERS Form:2
Age:79.0
Sex:Male
Location:Foreign
Vaccinated:2019-11-14
Onset:2020-03-30
Submitted:0000-00-00
Entered:2020-06-12
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLUA3: INFLUENZA (SEASONAL) (CHIROMAS) / NOVARTIS VACCINES AND DIAGNOSTICS 9153A1A / UNK - / OT

Administered by: Unknown      Purchased by: ??
Symptoms: Acute respiratory failure, Death, COVID-19

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died:2020-04-21
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Comments: None
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': ESSEQIRUS202003770

Write-up: Respiratory infection by COVID-19; Acute respiratory insufficiency; This is a spontaneous case reported by pharmacist to Regulatory Authority (reference number: ES-AEMPS-635507) and initially retrieved on 08-Jun-2020, concerning a 79-year-old, male patient. The patient''s medical history and concomitant medications were not reported. On 14-Nov-2019, the patient was administered Chiromas (TIV) [influenza vaccine, inactivated influenza virus surface antigen (subunit), egg-derived, mf59; route of administration: intramuscular, dose reported as one, batch number, anatomical location and expiry date: not reported] for flu vaccination. On 30-Mar-2020, four months and sixteen days after vaccination, the patient developed acute respiratory insufficiency and respiratory infection by COVID-19. On 21-Apr-2020, the patient died. Cause of death was acute respiratory insufficiency and respiratory infection by COVID-19. It was unknown if autopsy was done. The events of ?acute respiratory insufficiency'' and ?respiratory infection by COVID-19'' were considered serious due to the criterion of death. The reporter did not provide causality assessment to Chiromas (TIV). This case is linked with the case 202003587 (Regulatory Authority link). Company comment: A 79-year-old male patient developed COVID-19 and acute respiratory failure four months and sixteen days after vaccination with the suspect product Chiromas (TIV) for flu. Chronology seems unsuggestive. On 21-Apr-2020, the patient died. Cause of death was acute respiratory insufficiency and respiratory infection by COVID-19. It was unknown if autopsy was done. The patient''s medical history and concomitant medications were not reported. With information presented, causality is assessed as unrelated to the product for both events. COVID provides more plausible aetiology.; Sender''s Comments: A 79-year-old male patient developed COVID-19 and acute respiratory failure four months and sixteen days after vaccination with the suspect product Chiromas (TIV) for flu. Chronology seems unsuggestive. On 21-Apr-2020, the patient died. Cause of death was acute respiratory insufficiency and respiratory infection by COVID-19. It was unknown if autopsy was done. The patient''s medical history and concomitant medications were not reported. With information presented, causality is assessed as unrelated to the product for both events. COVID provides more plausible aetiology. ES-SEQIRUS-202003587:Regulatory authority link; Reported Cause(s) of Death: Respiratory infection by COVID-19; Acute respiratory insufficiency


Changed on 12/24/2020

VAERS ID: 873194 Before After
VAERS Form:2
Age:79.0
Sex:Male
Location:Foreign
Vaccinated:2019-11-14
Onset:2020-03-30
Submitted:0000-00-00
Entered:2020-06-12
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLUA3: INFLUENZA (SEASONAL) (CHIROMAS) / NOVARTIS VACCINES AND DIAGNOSTICS 9153A1A / UNK - / OT

Administered by: Unknown      Purchased by: ??
Symptoms: Acute respiratory failure, Death, COVID-19

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died:2020-04-21
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Comments: None
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': ESSEQIRUS202003770

Write-up: Respiratory infection by COVID-19; Acute respiratory insufficiency; This is a spontaneous case reported by pharmacist to Regulatory Authority (reference number: ES-AEMPS-635507) and initially retrieved on 08-Jun-2020, concerning a 79-year-old, male patient. The patient''s medical history and concomitant medications were not reported. On 14-Nov-2019, the patient was administered Chiromas (TIV) [influenza vaccine, inactivated influenza virus surface antigen (subunit), egg-derived, mf59; route of administration: intramuscular, dose reported as one, batch number, anatomical location and expiry date: not reported] for flu vaccination. On 30-Mar-2020, four months and sixteen days after vaccination, the patient developed acute respiratory insufficiency and respiratory infection by COVID-19. On 21-Apr-2020, the patient died. Cause of death was acute respiratory insufficiency and respiratory infection by COVID-19. It was unknown if autopsy was done. The events of ?acute ‘acute respiratory insufficiency'' and ?respiratory ‘respiratory infection by COVID-19'' were considered serious due to the criterion of death. The reporter did not provide causality assessment to Chiromas (TIV). This case is linked with the case 202003587 (Regulatory Authority link). Company comment: A 79-year-old male patient developed COVID-19 and acute respiratory failure four months and sixteen days after vaccination with the suspect product Chiromas (TIV) for flu. Chronology seems unsuggestive. On 21-Apr-2020, the patient died. Cause of death was acute respiratory insufficiency and respiratory infection by COVID-19. It was unknown if autopsy was done. The patient''s medical history and concomitant medications were not reported. With information presented, causality is assessed as unrelated to the product for both events. COVID provides more plausible aetiology.; Sender''s Comments: A 79-year-old male patient developed COVID-19 and acute respiratory failure four months and sixteen days after vaccination with the suspect product Chiromas (TIV) for flu. Chronology seems unsuggestive. On 21-Apr-2020, the patient died. Cause of death was acute respiratory insufficiency and respiratory infection by COVID-19. It was unknown if autopsy was done. The patient''s medical history and concomitant medications were not reported. With information presented, causality is assessed as unrelated to the product for both events. COVID provides more plausible aetiology. ES-SEQIRUS-202003587:Regulatory authority link; Reported Cause(s) of Death: Respiratory infection by COVID-19; Acute respiratory insufficiency


Changed on 12/30/2020

VAERS ID: 873194 Before After
VAERS Form:2
Age:79.0
Sex:Male
Location:Foreign
Vaccinated:2019-11-14
Onset:2020-03-30
Submitted:0000-00-00
Entered:2020-06-12
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLUA3: INFLUENZA (SEASONAL) (CHIROMAS) / NOVARTIS VACCINES AND DIAGNOSTICS 9153A1A / UNK - / OT

Administered by: Unknown      Purchased by: ??
Symptoms: Acute respiratory failure, Death, COVID-19

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died:2020-04-21
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Comments: None
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': ESSEQIRUS202003770

Write-up: Respiratory infection by COVID-19; Acute respiratory insufficiency; This is a spontaneous case reported by pharmacist to Regulatory Authority (reference number: ES-AEMPS-635507) and initially retrieved on 08-Jun-2020, concerning a 79-year-old, male patient. The patient''s medical history and concomitant medications were not reported. On 14-Nov-2019, the patient was administered Chiromas (TIV) [influenza vaccine, inactivated influenza virus surface antigen (subunit), egg-derived, mf59; route of administration: intramuscular, dose reported as one, batch number, anatomical location and expiry date: not reported] for flu vaccination. On 30-Mar-2020, four months and sixteen days after vaccination, the patient developed acute respiratory insufficiency and respiratory infection by COVID-19. On 21-Apr-2020, the patient died. Cause of death was acute respiratory insufficiency and respiratory infection by COVID-19. It was unknown if autopsy was done. The events of ‘acute ?acute respiratory insufficiency'' and ‘respiratory ?respiratory infection by COVID-19'' were considered serious due to the criterion of death. The reporter did not provide causality assessment to Chiromas (TIV). This case is linked with the case 202003587 (Regulatory Authority link). Company comment: A 79-year-old male patient developed COVID-19 and acute respiratory failure four months and sixteen days after vaccination with the suspect product Chiromas (TIV) for flu. Chronology seems unsuggestive. On 21-Apr-2020, the patient died. Cause of death was acute respiratory insufficiency and respiratory infection by COVID-19. It was unknown if autopsy was done. The patient''s medical history and concomitant medications were not reported. With information presented, causality is assessed as unrelated to the product for both events. COVID provides more plausible aetiology.; Sender''s Comments: A 79-year-old male patient developed COVID-19 and acute respiratory failure four months and sixteen days after vaccination with the suspect product Chiromas (TIV) for flu. Chronology seems unsuggestive. On 21-Apr-2020, the patient died. Cause of death was acute respiratory insufficiency and respiratory infection by COVID-19. It was unknown if autopsy was done. The patient''s medical history and concomitant medications were not reported. With information presented, causality is assessed as unrelated to the product for both events. COVID provides more plausible aetiology. ES-SEQIRUS-202003587:Regulatory authority link; Reported Cause(s) of Death: Respiratory infection by COVID-19; Acute respiratory insufficiency


Changed on 5/7/2021

VAERS ID: 873194 Before After
VAERS Form:2
Age:79.0
Sex:Male
Location:Foreign
Vaccinated:2019-11-14
Onset:2020-03-30
Submitted:0000-00-00
Entered:2020-06-12
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLUA3: INFLUENZA (SEASONAL) (CHIROMAS) / NOVARTIS VACCINES AND DIAGNOSTICS 9153A1A / UNK - / OT

Administered by: Unknown      Purchased by: ??
Symptoms: Acute respiratory failure, Death, COVID-19

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died:2020-04-21
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Comments: None
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': ESSEQIRUS202003770

Write-up: Respiratory infection by COVID-19; Acute respiratory insufficiency; This is a spontaneous case reported by pharmacist to Regulatory Authority (reference number: ES-AEMPS-635507) and initially retrieved on 08-Jun-2020, concerning a 79-year-old, male patient. The patient''s medical history and concomitant medications were not reported. On 14-Nov-2019, the patient was administered Chiromas (TIV) [influenza vaccine, inactivated influenza virus surface antigen (subunit), egg-derived, mf59; route of administration: intramuscular, dose reported as one, batch number, anatomical location and expiry date: not reported] for flu vaccination. On 30-Mar-2020, four months and sixteen days after vaccination, the patient developed acute respiratory insufficiency and respiratory infection by COVID-19. On 21-Apr-2020, the patient died. Cause of death was acute respiratory insufficiency and respiratory infection by COVID-19. It was unknown if autopsy was done. The events of ?acute ‘acute respiratory insufficiency'' and ?respiratory ‘respiratory infection by COVID-19'' were considered serious due to the criterion of death. The reporter did not provide causality assessment to Chiromas (TIV). This case is linked with the case 202003587 (Regulatory Authority link). Company comment: A 79-year-old male patient developed COVID-19 and acute respiratory failure four months and sixteen days after vaccination with the suspect product Chiromas (TIV) for flu. Chronology seems unsuggestive. On 21-Apr-2020, the patient died. Cause of death was acute respiratory insufficiency and respiratory infection by COVID-19. It was unknown if autopsy was done. The patient''s medical history and concomitant medications were not reported. With information presented, causality is assessed as unrelated to the product for both events. COVID provides more plausible aetiology.; Sender''s Comments: A 79-year-old male patient developed COVID-19 and acute respiratory failure four months and sixteen days after vaccination with the suspect product Chiromas (TIV) for flu. Chronology seems unsuggestive. On 21-Apr-2020, the patient died. Cause of death was acute respiratory insufficiency and respiratory infection by COVID-19. It was unknown if autopsy was done. The patient''s medical history and concomitant medications were not reported. With information presented, causality is assessed as unrelated to the product for both events. COVID provides more plausible aetiology. ES-SEQIRUS-202003587:Regulatory authority link; Reported Cause(s) of Death: Respiratory infection by COVID-19; Acute respiratory insufficiency

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=873194&WAYBACKHISTORY=ON


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166